Angels Lose Kochanowicz to Tommy John Surgery; Rotation Faces Immediate Void

By PropBetEdge Editorial Team ·

A torn UCL ends Jack Kochanowicz's season and threatens 2027 availability, forcing the Angels to reach into their farm system for a mid-season starter replacement.

Angels Lose Kochanowicz to Tommy John Surgery; Rotation Faces Immediate Void

The Angels' pitching timeline collapsed on Tuesday when right-hander Jack Kochanowicz was diagnosed with a torn ulnar collateral ligament requiring Tommy John surgery. Kochanowicz, 25, felt discomfort in his elbow Saturday while throwing changeups against the Dodgers and underwent an MRI Monday that confirmed the tear. He'll miss the remainder of 2026 and faces uncertainty heading into 2027—a multi-year setback for a prospect the team had been developing in the rotation.

The symptoms had been building. Over his final six starts before the diagnosis, Kochanowicz's ERA ballooned to 11.91 after posting a clean 3.05 through his first seven outings. His arm felt compromised for roughly a month, he said, but he'd been working through what he thought was general soreness rather than structural damage. Velocity remained intact (97 mph fastball in his last appearance), which masked the deterioration underneath. By the time imaging revealed the tear, the damage was done.

The immediate problem is roster management. With Kochanowicz gone, the Angels must slot a starter into their rotation within days. Manager Kurt Suzuki is weighing three candidates: lefty Sam Aldegheri (No. 16 prospect, recently called up), right-hander Caden Dana (six scoreless innings in Triple-A on Friday), and right-hander George Klassen (No. 4 prospect, mixed results in the minors last time out). None carry the experience or track record of a veteran depth arm, which means the Angels are betting on development-stage talent to eat innings during a season-long commitment.

For bettors, this creates a near-term volatility spike in Angels rotation pricing. Over the next 1-2 weeks, the Angels' starter prop lines will shift based on which arm gets the nod—and that decision was still undecided as of Suzuki's postgame comments. Aldegheri's recent relief appearance earned praise, and Dana's scoreless outing makes him the short-term favorite, but the market may overcorrect toward whichever name gets announced first. The safer angle is to fade Angels rotation strikeout props until the replacement is confirmed and has made at least one start; early-week lines on a TBA starter tend to be range-bound guesses rather than calibrated prices. Once Aldegheri, Dana, or Klassen throws their first game, the market will recalibrate. Betting before that clarity lands is noise with no mechanism to exploit.

Moncada's concurrent knee surgery (eligible to return July 21, roughly six weeks away) compounds the depth tax but is less disruptive—the Angels already have Denzer Guzman (No. 7 prospect) taking over at third base, and the position has secondary options. Kochanowicz's absence, however, removes a salaried rotation piece that can't be backfilled by internal talent without accepting elevated injury risk and inconsistency. The Angels' rotation lines should widen materially until the replacement starter takes the ball.